The global in vitro toxicology market is expected to grow from USD 15.30 billion in 2019 to USD 30.93 billion by 2027, at a CAGR of 9.2% during the forecast period 2020-2027.
In vitro toxicology is used in scientific analysis mainly in analyzing the toxic chemical substance and its effect on cultured bacteria. It is used to check the lack of poisonous properties and identify hazardous chemicals. It is also beneficial in the development of food additives, agricultural chemicals and therapeutic drugs. In vitro toxicology is cost-effective, time-effective and more useful than In vivo toxicology. The in vitro toxicology market is driven by increased research and development, technological innovations and advancements and opposition to animal testing. Also, rapid advances in the biomedical field, advanced in-vitro test as well as improvements in epigenetics, computational toxicology and bioinformatics are contributing factors in the growth of the market.
This study delivers a comprehensive analysis of technologies, applications and regions. The technology segment includes OMICS technology, molecular imaging, high throughput technology and cell culture technology. The cell culture segment has the largest share in the in-vitro toxicology market. It is due to the capability of mimicking in vivo conditions and preferred technique to test toxicity. It is widely used in laboratories to decipher the necessary toxicity screening. Cell culture is easy to use as well as affordable. The application segment includes dermal toxicity, phototoxicity testing, organ toxicity, ocular toxicity, cytotoxicity testing, genotoxicity testing, skin irritation, sensitization, corrosion and ADME. Organ toxicity is beneficial in the screening of potential drug targets in the drug development. The organ toxicity segment is expected to show the highest growth over the forecast period due to an increased focus on consumer-product safety and drug safety.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Asia Pacific is expected to show the highest growth in the in-vitro toxicology market. It is due to increased consumer awareness of product safety, pharmaceutical drug pipeline, opposition to animal testing and the emergence of CROs.
Some of the notable players in the in vitro toxicology market are Covance, GE Healthcare, Merck KGaA, Catalent Inc., SGS SA, Promega Corporation, BioIVT, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Cyprotex, QIAGEN N.V., Gentronix Limited, MB Research Laboratories. Merck has a strong global presence and is focusing more on expansions to increase its customer base. To supply its product, Merck has opened life science centres across the globe. Targeted acquisitions is also an essential strategy for Merck.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global In Vitro Toxicology Market Analysis And Forecast, By Technology
Global In Vitro Toxicology Market Analysis And Forecast, By Application
Global In Vitro Toxicology Market Analysis And Forecast, By Regional Analysis
Report Description:
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Technology
4.3.2. Market Attractiveness Analysis By Application
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restrains
5.4. Opportunities
5.5. Challenges
6. Global In Vitro Toxicology Market Analysis and Forecast, By Technology
6.1. Segment Overview
6.2. OMICS Technology
6.3. Molecular Imaging
6.4. High Throughput Technology
6.5. Cell Culture Technology
7. Global In Vitro Toxicology Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Dermal Toxicity
7.3. Phototoxicity Testing
7.4. Organ Toxicity
7.5. Ocular Toxicity
7.6. Cytotoxicity Testing
7.7. Genotoxicity Testing
7.8. Skin Irritation
7.9. Sensitization
7.10. Corrosion
7.11. ADME
8. Global In Vitro Toxicology Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global In Vitro Toxicology Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global In Vitro Toxicology Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Covance
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. GE Healthcare
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Merck KGaA
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Catalent Inc.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. SGS SA
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Promega Corporation
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. BioIVT
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Thermo Fisher Scientific Inc.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Bio-Rad Laboratories Inc.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Eurofins Scientific SE
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Charles River Laboratories International Inc.
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Cyprotex
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. QIAGEN N.V.
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
10.14. Gentronix Limited
10.14.1. Business Overview
10.14.2. Company Snapshot
10.14.3. Company Market Share Analysis
10.14.4. Company Product Portfolio
10.14.5. Recent Developments
10.14.6. SWOT Analysis
10.15. MB Research Laboratories
10.15.1. Business Overview
10.15.2. Company Snapshot
10.15.3. Company Market Share Analysis
10.15.4. Company Product Portfolio
10.15.5. Recent Developments
10.15.6. SWOT Analysis
List of Table
1. Global In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
2. Global OMICS Technology In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
3. Global Molecular Imaging In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
4. Global High Throughput Technology In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
5. Global Cell Culture Technology In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
6. Global In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
7. Global Dermal Toxicity In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
8. Global Phototoxicity Testing In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
9. Global Organ Toxicity In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
10. Global Ocular Toxicity In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
11. Global Cytotoxicity Testing In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
12. Global Genotoxicity Testing In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
13. Global Skin Irritation In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
14. Global Sensitization In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
15. Global Corrosion In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
16. Global ADME In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
17. Global In Vitro Toxicology Market, By Region, 2017–2027(USD Billion)
18. Global In Vitro Toxicology Market, By North America, 2017–2027(USD Billion)
19. North America In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
20. North America In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
21. U.S. In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
22. U.S. In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
23. Canada In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
24. Canada In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
25. Mexico In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
26. Mexico In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
27. Europe In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
28. Europe In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
29. Germany In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
30. Germany In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
31. France In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
32. France In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
33. U.K. In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
34. U.K. In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
35. Italy In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
36. Italy In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
37. Spain In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
38. Spain In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
39. Asia Pacific In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
40. Asia Pacific In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
41. Japan In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
42. Japan In Vitro Toxicology Market, By End Use Industry, 2017–2027(USD Billion)
43. China In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
44. China In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
45. India In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
46. India In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
47. South America In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
48. South America In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
49. Brazil In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
50. Brazil In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
51. Middle East and Africa In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
52. Middle East and Africa In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
53. UAE In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
54. UAE In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
55. South Africa In Vitro Toxicology Market, By Technology, 2017–2027(USD Billion)
56. South Africa In Vitro Toxicology Market, By Application, 2017–2027(USD Billion)
List of Figures
1. Global In Vitro Toxicology Market Segmentation
2. In Vitro Toxicology Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global In Vitro Toxicology Market Attractiveness Analysis By Technology
9. Global In Vitro Toxicology Market Attractiveness Analysis By Application
10. Global In Vitro Toxicology Market Attractiveness Analysis By Region
11. Global In Vitro Toxicology Market: Dynamics
12. Global In Vitro Toxicology Market Share By Technology (2019 & 2027)
13. Global In Vitro Toxicology Market Share By Application (2019 & 2027)
14. Global In Vitro Toxicology Market Share by Regions (2019 & 2027)
15. Global In Vitro Toxicology Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.